MedMen Enterprises - MMNFF Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.25
  • Forecasted Upside: 488.24 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.04
+0 (0.00%)

This chart shows the closing price for MMNFF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MedMen Enterprises Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MMNFF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MMNFF

Analyst Price Target is $0.25
▲ +488.24% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for MedMen Enterprises in the last 3 months. The average price target is $0.25, with a high forecast of $0.25 and a low forecast of $0.25. The average price target represents a 488.24% upside from the last price of $0.04.

This chart shows the closing price for MMNFF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 investment analysts is to hold stock in MedMen Enterprises.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/4/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/3/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/28/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/26/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/3/2021Cantor FitzgeraldLower TargetNeutral$0.30 ➝ $0.25
8/18/2021Cantor FitzgeraldUpgradeUnderweight ➝ Neutral$0.30
3/23/2021Cantor FitzgeraldReiterated RatingNeutral ➝ Underweight
3/17/2021Cantor FitzgeraldDowngradeNeutral ➝ Underweight
2/13/2020Cantor FitzgeraldInitiated CoverageNeutral
12/17/2019CowenUpgradeUnderperform ➝ Market Perform$0.75
9/13/2019CowenInitiated CoverageUnderperform
3/22/2019Northland SecuritiesSet TargetBuy$9.00
2/28/2019Northland SecuritiesReiterated RatingBuy$9.00
(Data available from 9/26/2017 forward)

News Sentiment Rating

0.55 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/28/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/30/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/29/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/29/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/28/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/28/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/27/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/26/2022

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

MedMen Enterprises logo
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. The company provides products under the MedMen Red and LuxLyte brand names. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts. MedMen Enterprises Inc. is based in Los Angeles, California.
Read More

Today's Range

Now: $0.04
Low: $0.04
High: $0.05

50 Day Range

MA: $0.06
Low: $0.04
High: $0.07

52 Week Range

Now: $0.04
Low: $0.04
High: $0.32

Volume

1,150,321 shs

Average Volume

2,120,406 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of MedMen Enterprises?

The following Wall Street analysts have issued stock ratings on MedMen Enterprises in the last twelve months: Cantor Fitzgerald.
View the latest analyst ratings for MMNFF.

What is the current price target for MedMen Enterprises?

1 Wall Street analysts have set twelve-month price targets for MedMen Enterprises in the last year. Their average twelve-month price target is $0.25, suggesting a possible upside of 488.2%. Cantor Fitzgerald has the highest price target set, predicting MMNFF will reach $0.25 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $0.25 for MedMen Enterprises in the next year.
View the latest price targets for MMNFF.

What is the current consensus analyst rating for MedMen Enterprises?

MedMen Enterprises currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MMNFF, but not buy more shares or sell existing shares.
View the latest ratings for MMNFF.

What other companies compete with MedMen Enterprises?

How do I contact MedMen Enterprises' investor relations team?

MedMen Enterprises' physical mailing address is 10115 Jefferson Boulevard, Culver City, CA 90232. The company's listed phone number is (855) 292-8399. The official website for MedMen Enterprises is www.medmen.com. Learn More about contacing MedMen Enterprises investor relations.